Spanish woman dies by euthanasia after legal battle over 2022 gang rape trauma
Spanish woman dies by euthanasia after legal battle over 2022 gang rape trauma
Spanish woman dies by euthanasia after legal battle over 2022 gang rape trauma
Noelia Castillo Ramos, a 25-year-old woman from Barcelona, has died by euthanasia after a lengthy legal struggle. Her case drew international attention following a traumatic gang rape in 2022 that left her paralysed. The decision came after multiple court rulings, including a final verdict from the European Court of Human Rights. Castillo's request for euthanasia began after she survived a violent assault in 2022. The attack resulted in severe injuries, including paralysis, and led to her repeated pleas to end her suffering. Initially, her father opposed the procedure, causing legal delays.
In 2024, Catalan authorities approved her request, but the process was temporarily blocked by her father's objections. The European Court of Human Rights later upheld her right to proceed, clearing the final hurdle. Spain's 2021 euthanasia law, which allows the procedure under strict conditions, has seen over 1,100 approved cases since its introduction. The case has reignited debates over euthanasia, particularly regarding mental health criteria and family consent. While euthanasia remains illegal in Russia, a 2019 VCIOM survey revealed that half of Russians support it for patients with severe illnesses. However, 81% opposed allowing it for all individuals over 60, regardless of health status. Currently, only nine countries worldwide permit euthanasia under specific conditions.
Castillo's euthanasia marks the end of a two-year legal battle that tested Spain's 2021 law. Her case has highlighted ongoing ethical and legal challenges surrounding end-of-life decisions. The ruling sets no immediate precedent for changes in other countries, where euthanasia laws remain unchanged since 2021.
Yakutsk's silent health crisis: High cholesterol fuels heart disease surge
Nearly 60% of residents screened have dangerous cholesterol—yet many ignore the warning signs. Could this campaign save lives before it's too late?
Wave Life Sciences stock crashes 50% after obesity drug disappoints in trial
A once-promising obesity drug stumbles in testing, wiping out half of Wave's market value. Can the next trial revive investor confidence?
MIT's implantable device could end daily insulin shots for diabetes patients
A tiny implant could revolutionize diabetes care by replacing needles with living cells. Early animal tests show months of stable glucose control—human trials are next.
Two elderly women hospitalized after near-fatal hot tub overheating in Kentucky
A relaxing getaway turned critical when two octogenarians nearly succumbed to hyperthermia. Their rescue exposes hidden dangers of hot tubs for older adults.
Heidelberg University's Univitality Health Week Puts Heart Health in Focus
From CPR training to Pilates, this four-day event blends science and sweat to empower students and staff. No sign-ups needed—just show up and thrive.
New Alzheimer's Drug FP802 Shows Promise in Slowing Disease Progression
Could a single compound halt Alzheimer's progression? FP802 blocks toxic proteins in mice, sparking hope for future human trials. But the road ahead is long.
US AI Action Plan Sparks Global Inequality and Climate Fears by 2025
A bold US push for AI dominance could reshape global tech—but at what cost? Developing nations fear job losses, climate strain, and deeper dependency on American systems.
Dual blood pressure drugs may offer stronger heart protection, study finds
Could two common blood pressure medications work better together? Scientists uncover surprising benefits for heart health—and fewer side effects than expected.